Chevreau C - Search Results

1

The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.

Loriot Y, Texier M, Culine S, Fléchon A, Thiery-Vuillemin A, Gravis G, Geoffrois L, Chevreau C, Gross-Goupil M, Barthelemy P, Bompas E, Mahammedi H, Laguerre B, Lacourtoisie SA, Helissey C, Ladoire S, Abraham C, Massard C, Grimaldi S, Fizazi K. Loriot Y, et al. Among authors: chevreau c. Eur Urol. 2022 Aug;82(2):172-179. doi: 10.1016/j.eururo.2022.04.031. Epub 2022 May 20. Eur Urol. 2022. PMID: 35599187 Clinical Trial.

2

Early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor risk non-seminomatous germ cell tumours. Preliminary results of a French randomized trial.

Chevreau C, Droz JP, Pico JL, Biron P, Kerbrat P, Cure H, Héron JF, Chevallier B, Fargeot P, Kramar A, et al. Chevreau C, et al. Eur Urol. 1993;23(1):213-7; discussion 218. doi: 10.1159/000474596. Eur Urol. 1993. PMID: 8386652 Clinical Trial.

3

Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: a multicenter phase II trial. Groupe Français d'Immunothérapie.

Ravaud A, Audhuy B, Gomez F, Escudier B, Lesimple T, Chevreau C, Douillard JY, Caty A, Geoffrois L, Ferrero JM, Linassier C, Drevon M, Négrier S. Ravaud A, et al. Among authors: chevreau c. J Clin Oncol. 1998 Aug;16(8):2728-32. doi: 10.1200/JCO.1998.16.8.2728. J Clin Oncol. 1998. PMID: 9704724 Clinical Trial.

4

Second non-germ cell malignancies in patients treated for stage I-II testicular seminoma.

Bachaud JM, Berthier F, Soulié M, Malavaud B, Plante P, Rischmann P, Chevreau C, Daly-Schveitzer N, Grosclaude P. Bachaud JM, et al. Among authors: chevreau c. Radiother Oncol. 1999 Feb;50(2):191-7. doi: 10.1016/s0167-8140(98)00101-7. Radiother Oncol. 1999. PMID: 10368043

5

Pure seminoma in a male phenotype 46,XX true hermaphrodite.

Malavaud B, Mazerolles C, Bieth E, Chevreau C, Le Frere MA, Alric L. Malavaud B, et al. Among authors: chevreau c. J Urol. 2000 Jul;164(1):125-6. J Urol. 2000. PMID: 10840442 No abstract available.

6

Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers.

Escudier B, Droz JP, Rolland F, Terrier-Lacombe MJ, Gravis G, Beuzeboc P, Chauvet B, Chevreau C, Eymard JC, Lesimple T, Merrouche Y, Oudard S, Priou F, Guillemare C, Gourgou S, Culine S; Genitourinary Group of the French Federation of Cancer Centers. Escudier B, et al. Among authors: chevreau c. J Urol. 2002 Sep;168(3):959-61. doi: 10.1016/S0022-5347(05)64551-X. J Urol. 2002. PMID: 12187199 Clinical Trial.

7

A phase II study with 5-fluorouracil, folinic acid and oxaliplatin (FOLFOX-4 regimen) in patients with metastatic renal cell carcinoma.

Bennouna J, Delva R, Gomez F, Lesimple T, Geoffrois L, Linassier C, Chevreau C, Douillard JY, Négrier S. Bennouna J, et al. Among authors: chevreau c. Oncology. 2003;64(1):25-7. doi: 10.1159/000066518. Oncology. 2003. PMID: 12457028 Clinical Trial.

8

A phase II study of irinotecan in patients with advanced renal cell carcinoma.

Fizazi K, Rolland F, Chevreau C, Droz JP, Mery-Mignard D, Culine S, Escudier B. Fizazi K, et al. Among authors: chevreau c. Cancer. 2003 Jul 1;98(1):61-5. doi: 10.1002/cncr.11474. Cancer. 2003. PMID: 12833456 Free article. Clinical Trial.

9

Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and/or vascular invasion.

Chevreau C, Mazerolles C, Soulié M, Gaspard MH, Mourey L, Bujan L, Plante P, Rischmann P, Bachaud JM, Malavaud B. Chevreau C, et al. Eur Urol. 2004 Aug;46(2):209-14; discussion 214-5. doi: 10.1016/j.eururo.2004.03.022. Eur Urol. 2004. PMID: 15245815 Review.

10

Gemcitabine and cisplatin after radical cystectomy for bladder cancer in an adjuvant setting: feasibility study from the Genito-Urinary Group of the French Federation of Cancer Centers.

Fléchon A, Fizazi K, Gourgou-Bourgade S, Théodore C, Beuzeboc P, Geoffrois L, Mottet N, Chevreau C, Culine S. Fléchon A, et al. Among authors: chevreau c. Anticancer Drugs. 2006 Jul;17(6):705-8. doi: 10.1097/01.cad.0000210337.85526.cc. Anticancer Drugs. 2006. PMID: 16917216

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

314 results

Search Page